An embedded physician escalation desk for your denial operation.
Your team handles volume. Clinovian handles the clinical escalations your coders and appeal writers escalate — white-label or co-branded.
Your team handles denial volume well. The clinically hard cases stall.
Medical-necessity denials involving complex comorbidity arguments, level-of-care disputes, DRG downgrades, and criteria-interpretation challenges require physician-level reasoning that your coders and appeal writers are not expected to provide. Those cases either get under-argued, deprioritized, or stuck.
What you keep. What we provide.
You keep: the client relationship, the workflow, the submission, the credit. We provide: the physician-level clinical argument as a fixed-format memo your team uses to complete the appeal. White-label available — your brand, Clinovian's physician reasoning.
Route hard cases
Your team flags cases that exceed coder/appeal-writer scope. Send de-identified.
Suitability check
We confirm the case is suitable for physician escalation within 24–48 hours.
Memo delivered
Fixed-format Escalation Memo, 48–72 hours. Your appeal writer uses it directly.
Pattern reports
Denial-trend intelligence across your escalated cases — payer, service line, rationale type. Available to recurring-capacity partners.
Retain & grow
The pattern intelligence becomes a retention and upsell tool for your client relationships.
Complex-dossier review
Your team retains eligibility, batching, offer, portal, deadline, and filing control. Clinovian reviews the clinical record and authors the evidence layer for selected complex disputes.
Analyst and AI narrative validation
Independent physician review for unsupported inferences, duplicated arguments, QPA/offer confusion, and clinical facts that are weakly mapped to the record.
IDR Clinical QA Desk
Fixed monthly physician capacity for an agreed number of escalations, with private batch-framework and exception-sampling options for qualified partners.
Boundary: Clinovian does not access the Federal IDR portal, determine eligibility, validate coding, select offers, pay process fees, or provide legal representation.
Suitability screen with explicit rules
Every routed case passes a de-identified suitability screen under accept/decline rules agreed at onboarding. Some routed cases will be declined as unsuitable — that selectivity is what keeps the output credible for your client.
Agreed deliverable templates
Memo, brief, and QA formats agreed in advance, so the output drops directly into your workflow instead of arriving as free-form consulting.
Fixed unit fees or reserved capacity
Per-deliverable fees or reserved monthly capacity — never hourly — with consolidated invoicing on a single monthly invoice.
White-label with credential transparency
Your brand on the delivery under agreed branding rules. White-label delivery never conceals authorship credentials or implies U.S. licensure your client is not receiving.
Revision controls & audit trail
Agreed correction rules and a traceable version history for every deliverable — so quality disputes are resolved from the record, not from memory.
Pattern summaries from your data
Payer, service-line, and rationale-type patterns built only from the cases and outcomes you supply — available to recurring-capacity partners.
Contact boundary. Clinovian has no direct contact with your client, the payer, or the patient unless separately authorized and appropriate. The relationship, the workflow, and the credit remain yours.
- Stable intake and clear escalation routing — your team decides which cases exceed coder and appeal-writer scope
- Secure data handling and a BAA workflow before any records move
- Qualified client-facing staff who own submission, filing, and payer communication
- Authoritative policy and criteria access for the cases you escalate
- Acceptance that clinically unsupportable cases will be declined, with the reason stated
From five deliverables per month
Reserved monthly capacity with suitability triage on incoming cases, a prevention note on every memo, outcome tracking at 60–90 days where you supply disposition and payment data, and a Quarterly Impact Summary. Scoped after a de-identified review of the recurring case profile.
Best fit for partnership:
- → Denial-management firms
- → RCM firms with denial-management service lines
- → AI appeal / AI-RCM vendors
- → Utilization review consultants
- → Appeal-writing teams
Not the best fit:
- · General billing shops looking for low-dollar first-pass rework
- · Eligibility and benefits verification teams
- · High-volume, low-complexity denial processing
What the review must resolve before a defensible handoff.
Intake
How will the partner submit de-identified suitability summaries and resolve missing inputs?
Named artifact
Which memo, brief, QA, dossier, or audit output is assigned to each accepted case?
Credential transparency
How will branding avoid implying U.S. licensure, coding, legal, IRO, or representative status?
Quality
What template, source trail, correction round, and change-of-scope rule apply?
Reporting
Which outcomes will the partner return and how will missing denominators remain visible?
What the client provides.
Scope and turnaround begin after the agreed inputs are complete enough for a responsible review. A larger record is not automatically a better record.
- Representative cases and current partner outputs
- Expected case mix, volume, turnaround, and peak periods
- Partner responsibilities for filing, follow-up, coding, client communication, and deadlines
- Branding and credential-disclosure requirements
- Security, BAA, transfer, retention, and access requirements
- Outcome and quality feedback process
What the analysis is designed to prevent.
The page does not assume the adverse decision is wrong. It identifies ways a supportable case can become inaccurate, overstated, or misrouted.
- Using Clinovian as an invisible licensed physician substitute
- Routing routine volume without suitability rules
- Allowing incompatible end-client formats and SLAs
- Reporting win rate from incomplete outcomes
- Expecting direct payer or end-client contact by default
How this service fits among current alternatives.
- Hire or contract U.S.-licensed physician advisors.
- Subcontract a physician-advisory firm.
- Use a denial-management platform with embedded clinical services.
- Build an internal clinician/coder escalation pool.
- Use AI generation plus internal clinical QA.
- Refer complex cases to a full-service recovery firm.
The U.S. physician-advisor employment alternative can be costly: one current hospital posting lists $206,606–$413,212 before benefits/overhead. It also includes broader duties and licensed capability, so it is not equivalent to Clinovian. (AdventHealth)
What can—and cannot—be compared.
Subcontract physician-advisor and enterprise clinical-denial prices are private. Alternatives are bought as salary, retainer, per-case fee, subscription, or contingency. A transparent unit model is more comparable to Clinovian’s actual scope than a percentage of the partner’s recovery.
When the service is the right instrument.
Choose it when the RCM partner has stable intake, secure data handling, qualified client-facing staff, and a genuine gap in complex clinical reasoning. Do not choose it when the partner expects Clinovian to supply a U.S.-licensed signature, accept every case, hide credentials, guarantee outcomes, or assume end-client obligations without a direct and approved structure.
Start with a structured evaluation from your workflow.
Send three matters your team has escalated. See the output before committing to a recurring arrangement.